We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TCF market cap is 2.67M. The company's latest EPS is GBP -0.0073 and P/E is -0.85.
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 0 | 194k | 0 | 422k | 396k |
Operating Income | -3.15M | -3.2M | -3.19M | -5.07M | -3.56M |
Net Income | -2.72M | -2.67M | -2.73M | -4.04M | -3.14M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 4.86M | 12.42M | 9.64M | 6.17M | 3.06M |
Total Liabilities | 653k | 607k | 411k | 833k | 721k |
Total Equity | 4.2M | 11.81M | 9.23M | 5.34M | 2.34M |
Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -2.58M | -2.93M | -2.58M | -4.13M | -3M |
Investing | 1,000 | -6.01M | 1.5M | 4.62M | N/A |
Financing | 4.68M | 10.39M | N/A | N/A | N/A |
Market Cap | 2.67M |
Price to Earnings Ratio | -0.85 |
Price to Sales Ratio | 6.89 |
Price to Cash Ratio | 1.32 |
Price to Book Ratio | 1.13 |
Dividend Yield | - |
Shares Outstanding | 427.35M |
Average Volume (1 week) | 374.11k |
Average Volume (1 Month) | 363.16k |
52 Week Change | -98.21% |
52 Week High | 35.00 |
52 Week Low | 0.59 |
Spread (Intraday) | 0.05 (7.69%) |
Company Name | Theracryf Plc |
Address |
alderley park cheshire SK10 4TG |
Website | https://www.evgen.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions